Security National Bank’s AstraZeneca AZN Stock Holding History

Security National Bank’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.7M	Buy	+8,964	New	+$1.69M	0.2%	76

Other funds holding AZN

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

ZIC

ZWJ Investment Counsel Atlanta, Georgia $3.09B AUM 39.43% 1-Year Est. Return

CAM

Cidel Asset Management Toronto, Ontario, Ontario, Canada $2.08B AUM 24.89% 1-Year Est. Return

SAM

Sycomore Asset Management Paris, France $932M AUM 51.25% 1-Year Est. Return

PAS

Professional Advisory Services Vero Beach, Florida $836M AUM 25.79% 1-Year Est. Return

MIM

Martin Investment Management Palm Beach Gardens, Florida $300M AUM 6.05% 1-Year Est. Return

NONA

Ninety One North America New York $2.13B AUM 9.16% 1-Year Est. Return

Security National Bank's AZN Position: Q2 2026 in Review

Security National Bank opened a new position in AstraZeneca (AZN) in Q2 2026: 8,964 shares worth $1.7M. The stake represents 0.2% of the portfolio and ranks #76 among its holdings.

233 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Security National Bank held 8,964 shares of AstraZeneca worth $1.7M as of Q2 2026.
AstraZeneca was a new Security National Bank position in Q2 2026.
AstraZeneca made up 0.2% of Security National Bank's portfolio in Q2 2026, its #76 holding.
233 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Security National Bank's 13F filing for Q2 2026, filed 15 Jul 2026.